WASHINGTON, D.C. – Today, U.S. Senator Thom Tillis (R-NC) issued the following statement on the announcement by FUJIFILM Diosynth Biotechnologies to build a new drug product manufacturing facility and bring hundreds of jobs to Holly Springs, North Carolina:
“Today’s announcement by FUJIFILM Diosynth Biotechnologies to invest more than one billion dollars and bring hundreds of jobs to North Carolina is fantastic news and shows our state’s continued commitment to invest in a robust and sustained talent pipeline for life sciences. I recently spoke to FUJIFILM Diosynth Biotechnologies CEO Martin Meeson about making this new drug product manufacturing facility a reality, and I was proud to advocate on behalf of our great state on all we have to offer. FUJIFILM’s investment should be a model for future economic development pursuits across North Carolina—leveraging federal, state, and local officials, as well as private sector partners, and working together to land transformative projects for working families in North Carolina.”
“Today’s announcement by FUJIFILM Diosynth Biotechnologies to invest more than one billion dollars and bring hundreds of jobs to North Carolina is fantastic news and shows our state’s continued commitment to invest in a robust and sustained talent pipeline for life sciences. I recently spoke to FUJIFILM Diosynth Biotechnologies CEO Martin Meeson about making this new drug product manufacturing facility a reality, and I was proud to advocate on behalf of our great state on all we have to offer. FUJIFILM’s investment should be a model for future economic development pursuits across North Carolina—leveraging federal, state, and local officials, as well as private sector partners, and working together to land transformative projects for working families in North Carolina.”
###
